Quick Answer
VERACYTE, INC. reported Research And Development Expense of $70.81 million for the year ending 2025.
- VERACYTE, INC. showed an increase of +2.2% in Research And Development Expense from 2024 to 2025.
- This data is from VERACYTE, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), VERACYTE, INC.'s Research And Development Expense has grown by 960.1%.
- Historical annual values: Fiscal year 2025: $70.81 million | Fiscal year 2024: $69.29 million | Fiscal year 2023: $57.31 million | Fiscal year 2022: $40.60 million | Fiscal year 2021: $29.84 million | Fiscal year 2020: $17.20 million | Fiscal year 2019: $14.85 million | Fiscal year 2018: $14.82 million | Fiscal year 2017: $13.88 million | Fiscal year 2016: $15.32 million | Fiscal year 2015: $12.80 million | Fiscal year 2014: $9.80 million | Fiscal year 2013: $7.81 million | Fiscal year 2012: $6.61 million | Fiscal year 2011: $6.68 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: